HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distal spinal muscular atrophy featured by predominant calf muscle involvement in VRK1 associated disease - Case series and review.

Abstract
We describe the shared clinical, biochemical, radiological and myopathological characteristics of four patients with distal spinal muscular atrophy (dSMA) caused by vaccinia-related kinase 1 (VRK1) variants and provide a review of the literature on phenotype-genotype correlations in VRK1-related disease. The clinical phenotype was characterized by adult-onset dSMA with predominant calf muscle involvement and mildly elevated serum creatinine kinase (CK) levels. Muscle imaging showed predominant atrophy and fatty replacement of calf muscles. We identified the novel compound heterozygous variants c.607C>T (p.Arg203Trp) and c.858G>T (p.Met286Ile) in two siblings with adult-onset dSMA. Additionally, two unrelated patients both carried the known c.583T>G (p.Leu195Val) VRK1 variant, with either c.197C>G (p.Ala66Gly) or c.701A>G (p.Asn234Ser) as a second variant. We conclude that compound heterozygous VRK1 variants cause distal spinal muscular atrophy with predominant posterior leg muscle involvement.
AuthorsKoen Demaegd, Eva H Brilstra, Jessica E Hoogendijk, Charlotte I de Bie, Mirjam S de Pagter, Wim van Hecke, Angelika Mühlebner, Michael A van Es, Margherita Milone, Wouter van Rheenen
JournalNeuromuscular disorders : NMD (Neuromuscul Disord) Vol. 32 Issue 6 Pg. 527-532 (06 2022) ISSN: 1873-2364 [Electronic] England
PMID35641352 (Publication Type: Case Reports, Review)
CopyrightCopyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • Protein Serine-Threonine Kinases
  • VRK1 protein, human
Topics
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Leg
  • Muscle, Skeletal (diagnostic imaging)
  • Muscular Atrophy
  • Muscular Atrophy, Spinal (genetics)
  • Pedigree
  • Protein Serine-Threonine Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: